B Acute Lymphoblastic Leukemia, BCR-ABL1-Like

hematologic malignancy

Identifier: CI-CAN-00007270
Entity page: /cancer/b-acute-lymphoblastic-leukemia-bcr-abl1-like ↗
Edges: 29

Neighbours: 22 drugs7 trials
Drawn: 29 of 29 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
B Acute Lymphoblastic Leukemia, BCR-ABL1-Like investigated in trials for …INVESTIGATED_IN_TRIALSderived22 of 22show fewer
→ investigated in trials for	Cyclophosphamidesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	B Acute Lymphoblastic Leukemia, BCR-ABL1-Like	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Cytarabine

B Acute Lymphoblastic Leukemia, BCR-ABL1-Like studied in …STUDIED_INderived7 of 7
→ studied in	NCT05602194Phase 3 · active not recruiting Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma · condition mapped CURATED_BROADER · 7 trials mapped (3 active)	—	—	B Acute Lymphoblastic Leukemia, BCR-ABL1-Like	1	Observed	clinicaltrials	graph →
→ studied in	NCT02883049Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations · condition mapped CURATED_BROADER · 7 trials mapped (3 active)	—	—	B Acute Lymphoblastic Leukemia, BCR-ABL1-Like	1	Observed	clinicaltrials	graph →
→ studied in	NCT05157971Phase 1 · active not recruiting Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia · condition mapped ALIAS · 7 trials mapped (3 active)	—	—	B Acute Lymphoblastic Leukemia, BCR-ABL1-Like	1	Observed	clinicaltrials	graph →
→ studied in	NCT07454226NA · recruiting ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL · condition mapped ALIAS · 7 trials mapped (3 active)	—	—	B Acute Lymphoblastic Leukemia, BCR-ABL1-Like	1	Observed	clinicaltrials	graph →
→ studied in	NCT04501614Phase 1/Phase 2 · terminated A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia · condition mapped ALIAS · 7 trials mapped (3 active)	—	—	B Acute Lymphoblastic Leukemia, BCR-ABL1-Like	1	Observed	clinicaltrials	graph →
→ studied in	NCT02420717Phase 2 · terminated Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 7 trials mapped (3 active)	—	—	B Acute Lymphoblastic Leukemia, BCR-ABL1-Like	1	Observed	clinicaltrials	graph →
→ studied in	NCT03579888Phase 1 · terminated CD19-Specific T Cells Post AlloSCT · condition mapped CURATED_BROADER · 7 trials mapped (3 active)	—	—	B Acute Lymphoblastic Leukemia, BCR-ABL1-Like	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains